Clinical Trial Update: Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lung bioavailability and systemic exposure of Beclomethasone17MonoPropionate and Formoterol across two strengths of the NEXThaler inhal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclomethasone17MonoPropionate (Beclomethasone-17-Monopropionate)
• Formoterol (formoterol)
• NEXThaler

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthmatic | Phase 2 | Status: COMPLETED